Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Remme

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
British Heart Journal|November 1, 1985
Bleeding complications of intracoronary fibrinolytic therapy in acute myocardial infarction. Assessment of risk in a randomised trialF W Verheugt, M J van Eenige, J C Res, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1986
Effects of intracoronary thrombolysis on global left ventricular function assessed by an automated edge detection techniqueE E van der Wall, J C Res, M J van Eenige, et al.
Heart (British Cardiac Society)|January 24, 2007
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)Christian Torp-Pedersen, Marco Metra, Andrew Charlesworth, et al.
British Heart Journal|November 1, 1986
Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarctionJ C Res, M L Simoons, E E van der Wall, et al.
European Heart Journal|May 29, 2008
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physiciansWillem J Remme, John J V McMurray, F D Richard Hobbs, et al.
American Heart Journal|April 23, 2005
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMETChristian Torp-Pedersen, Philip A Poole-Wilson, Karl Swedberg, et al.
Cardiovascular Drugs and Therapy|May 27, 2004
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET)John G F Cleland, Kevin Goode, Leif Erhardt, et al.
Pathologie-Biologie|January 1, 1978
The prognosis of aplastic anaemia (AA) and the indication for bone marrow transplantation [proceedings]H L Haak, J T Velde, J Hermans, et al.
The American Journal of Cardiology|April 6, 2013
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery diseaseLinda Battes, Rogier Barendse, Ewout W Steyerberg, et al.
Journal of the American College of Cardiology|March 6, 2007
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMETWillem J Remme, Christian Torp-Pedersen, John G F Cleland, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
British Heart Journal|November 1, 1985
Bleeding complications of intracoronary fibrinolytic therapy in acute myocardial infarction. Assessment of risk in a randomised trialF W Verheugt, M J van Eenige, J C Res, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1986
Effects of intracoronary thrombolysis on global left ventricular function assessed by an automated edge detection techniqueE E van der Wall, J C Res, M J van Eenige, et al.
Heart (British Cardiac Society)|January 24, 2007
Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)Christian Torp-Pedersen, Marco Metra, Andrew Charlesworth, et al.
British Heart Journal|November 1, 1986
Long term improvement in global left ventricular function after early thrombolytic treatment in acute myocardial infarction. Report of a randomised multicentre trial of intracoronary streptokinase in acute myocardial infarctionJ C Res, M L Simoons, E E van der Wall, et al.
European Heart Journal|May 29, 2008
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physiciansWillem J Remme, John J V McMurray, F D Richard Hobbs, et al.
American Heart Journal|April 23, 2005
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMETChristian Torp-Pedersen, Philip A Poole-Wilson, Karl Swedberg, et al.
Cardiovascular Drugs and Therapy|May 27, 2004
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET)John G F Cleland, Kevin Goode, Leif Erhardt, et al.
Pathologie-Biologie|January 1, 1978
The prognosis of aplastic anaemia (AA) and the indication for bone marrow transplantation [proceedings]H L Haak, J T Velde, J Hermans, et al.
The American Journal of Cardiology|April 6, 2013
Development and validation of a cardiovascular risk assessment model in patients with established coronary artery diseaseLinda Battes, Rogier Barendse, Ewout W Steyerberg, et al.
Journal of the American College of Cardiology|March 6, 2007
Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMETWillem J Remme, Christian Torp-Pedersen, John G F Cleland, et al.
Pageof 24